Antibacterial Effect of Silver and Iron Oxide Nanoparticles in Combination with Antibiotics on E. coli K12
Antibiotic resistance is one of the main public health problems. The increase in the occurrence of multi-resistant pathogenic strains of bacteria due to biofilm formation gradually leads to inefficiency of traditional antibiotics. There are many strategies to combat biofilms, such as nanotechnologies. It is extremely important and relevant for nanomedicine to understand how the exposure of metal nanoparticles affects living organisms. The aim was to study the synergistic antibacterial activity of silver (AgNPs) and iron oxide (Fe3O4NPs) nanoparticles in combination with tetracycline (Tet) and ampicillin (Amp). The tests were performed against the wild strain E. coli K12. Our results suggest that both Fe3O4NPs and AgNPs form complexes with Amp and Tet. Fe3O4NPs slow down and AgNPs suppress the growth of E. coli at high concentrations. Dose-dependent inhibition of E. coli K12 growth is observed for AgNPs and Tet-AgNPs. The synergistic antibacterial effect is likely due to enhanced bacterial binding by AgNPs, which is assisted by Tet, but not by Amp. Fe3O4NPs do not exhibit bacterial growth inhibitory activity, but in combination with Amp, antagonism is observed. Fe3O4NPs slightly enhance the antibacterial effect of Tet. The antibacterial effect of Amp and Tet decreases when used in combination with AgNPs. Fe3O4NPs reduce the inhibitory effect of antibiotics on the formation of microcolonies. AgNPs suppress the growth of microcolonies, and in combination with Tet, the effects are enhanced. We hypothesize that the synergistic antibacterial activity correlates with the complex formation between NPs and the antibiotics. We propose pathways which lead to the synergistic effect.
KeywordsSilver nanoparticles Iron oxide nanoparticles Antibacterial effect Antibiotics E. coli K12
The authors thank Rshtuni L (Russian-Armenian University) for the help with synthesis of nanoparticles. The work was performed in the framework of the Program for Basic Research of Russian State Academies of Sciences for 2018.
Compliance with Ethical Standards
Conflict of Interest
Research Involving Humans and Animals Statement
- 1.Ali, S. G., Ansari, M. A., Khan, H. M., Jalal, M., Mahdi, A. A., & Cameotra, S. (2017). Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa. Journal of Basic Microbiology, 57(3), 193–203.Google Scholar
- 2.Allahverdiyev, A., Kon, K., Abamor, E., Bagirova, M., & Rafailovich, M. (2011). Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Review of Anti-Infective Therapy, 9(11), 1035–1052. https://doi.org/10.1586/eri.11.121.CrossRefGoogle Scholar
- 3.Ansari, M. A., Khan, H. M., Khan, A. A., Cameotra, S. S., & Alzohairy, M. A. (2015). Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital. Indian Journal of Medical Microbiology, 33(1), 101–109. https://doi.org/10.4103/0255-0857.148402.CrossRefGoogle Scholar
- 6.Borcherding, J., Baltrusaitis, J., Chen, H., Stebounova, L., Wu, C.-M., Rubasinghege, G., Mudunkotuwa, I., Caraballo, C., Zabner, J., Grassian, V., & Comellas, A. (2014). Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function. Environmental Science Nano, 1, 123–132. https://doi.org/10.1039/C3EN00029J.CrossRefGoogle Scholar
- 7.Cerceo, E., Deitelzweig, S. B., Sherman, B. M., & Amin, A. N. (2016). Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microbial Drug Resistance, 22(5), 412–431. https://doi.org/10.1089/mdr.2015.0220.CrossRefGoogle Scholar
- 10.CLSI M100S. (2017). Performance standards for antimicrobial susceptibility testing, ed. In 27.Google Scholar
- 12.Deng, H., McShan, D., Zhang, Y., Sinha, S., Arslan, Z., Ray, P. C., & Yu, H. (2016). Mechanistic study of the synergistic antibacterial activity of combined silver nanoparticles and common antibiotics. Environmental Science & Technology, 50(16), 8840–8848. https://doi.org/10.1021/acs.est.6b00998.CrossRefGoogle Scholar
- 13.do Nascimento, T., de Jesus Oliveira, E., Basilio Junior, I., de Araujo -Junior, J., & Macedo, R. (2013). Short -term stability studies of ampicillin and cephalexin in aqueous solution and human plasma: application of least squares method in Arrhenius equation. Journal of Pharmaceutical and Biomedical Analysis, 73, 59–64. https://doi.org/10.1016/j.jpba.2012.04.010.CrossRefGoogle Scholar
- 17.Ghosh, S., Patil, S., Ahire, M., Kitture, R., Kale, S., Pardesi, K., Cameotra, S., Bellare, J., Dhavale, D., & Jabgunde, A. (2012). Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. International Journal of Nanomedicine, 7, 483–496. https://doi.org/10.2147/IJN.S24793.Google Scholar
- 22.Kalishwaralal, K., BarathManiKanth, S., Pandian, S. R., Deepak, V., & Gurunathan, S. (2010). Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids and Surfaces. B, Biointerfaces, 79(2), 340–344. https://doi.org/10.1016/j.colsurfb.2010.04.014.CrossRefGoogle Scholar
- 23.Kang, F., Alvarez, P., & Zhu, D. (2014). Microbial extracellular polymeric substances reduce Ag+ to silver nanoparticles and antagonize bactericidal activity. Environmental Science & Technology, 48(1), 316–322. https://doi.org/10.1021/es403796x.
- 25.Li, P., Li, J., Wu, C., Wu, Q., & Li, J. (2005). Synergistic effect of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology, 16(9), 1912–1917. https://doi.org/10.1088/0957-4484/16/9/082.
- 26.Liu, H., Zhao, Y., Zhao, D., Gong, T., Wu, Y., Han, H., Xu, T., Peschel, A., Han, S., & Qu, D. (2015). Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Emergency Microbes and Infection, 4(1), e1.Google Scholar
- 31.McShana, D., Zhanga, Y., Denga, H., Raya, P., & Yua, H. (2015). Synergistic antibacterial effect of silver nanoparticles combined with ineffective antibiotics on drug resistant Salmonella typhimurium DT104. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 33(3), 369–384. https://doi.org/10.1080/10590501.2015.1055165.CrossRefGoogle Scholar
- 34.Radzig, M., Nadtochenko, V., Koksharova, O., Kiwi, J., Lipasova, V., & Khmel, I. (2013). Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids and Surfaces, B: Biointerfaces, 102, 300–306. https://doi.org/10.1016/j.colsurfb.2012.07.039.CrossRefGoogle Scholar
- 38.Vardanyan, Z., Gevorkyan, V., Ananyan, M., Vardapetyan, H., & Trchounian, A. (2015). Effects of various heavy metal nanoparticles on Enterococcus hirae and Escherichia coli growth and proton-coupled membrane transport. Journal of Nanbiotechnology, 13, 69. https://doi.org/10.1186/s12951-015-0131-3.CrossRefGoogle Scholar
- 42.Zhuang, L., Zhang, W., Zhao, Y., Shen, H., Lin, H., & Liang, J. (2015). Preparation and characterization of Fe3O4 particles with novel nanosheets morphology and magnetochromatic property by a modified solvothermal method. Scientific Reports, 5, 9320. https://doi.org/10.1038/srep09320.